Mark C. Wiggins, Chief Business Officer at Tracon Pharmaceuticals, Inc. (TCON), bought 7,000 shares at $4.14 ($29K) on 2020-09-10, disclosed to the SEC on 2020-09-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TCON | BUY | 2020-01-24 | $20K | — | Filing → |
| ZGNX | SELL | 2019-08-12 | $313K | — | Filing → |
| BIIB | SELL | 2008-09-29 | $37K | — | Filing → |